406 records matched your query
02881aam a2200337Ia 4500 001 2F0DCCD26B5811E69AFE1DDBDAD10320 003 SILO 005 20160826010517 008 150624s2015 dcua b 100 0 eng 020 $a 030936857X 020 $a 9780309368575 035 $a (OCoLC)911511666 040 $a NRZ $c NRZ $d NRZ $d IWA $d SILO 245 00 $a Policy issues in the development and adoption of biomarkers for molecularly targeted cancer therapies : $b workshop summary / $c Sharyl J. Nass, Jonathan Phillips, and Margie Patlak, rapporteurs ; National Cancer Policy Forum, Board on Health Care Services, Institute of Medicine of the National Academies. 264 1 $a Washington, D.C. : $b National Academies Press, $c [2015]. 300 $a xx, 85 pages : $b illustrations ; $c 23 cm. 500 $a " ... the National Cancer Policy Forum held a workshop, "Policy Issues in the Development and Adoption of Molecularly Targeted Therapies for Cancer," at Ohio State University in Columbus, Ohio, on November 10-11, 2014"--p. 81-85. 504 $a Includes bibliographical references (p. 76-80). 520 $a "One of the challenges in treating cancer is the disease's complexity and variation among patients. Cancer manifests differently in each patient, so treatments that are effective in one patient may not be effective in another. As cancer care becomes more personalized, subpopulations of individuals will be given preventive or therapeutic interventions based on their susceptibility to a particular disease or their predicted response to a specific treatment. However, before the use of personalized cancer care can reach its full potential, the health care system must resolve a number of technological, regulatory, and reimbursement issues. To explore these policy challenges, the National Cancer Policy Forum held the workshop Policy Issues in the Development of Personalized Medicine in Oncology in June 2009. Experts provided presentations on the current state of personalized medicine technology, as well as issues in the validation of, regulation of, and reimbursement for the predictive tests that underpin personalized medicine. Participants discussed the obstacles and possible solutions to further developing and using personalized medicine technologies. This document summarizes the workshop."--Publisher's description. 650 0 $a Cancer $x Treatment $z United States. 650 0 $a Cancer $x Genetic aspects. 650 0 $a Biochemical markers. 700 1 $a Patlak, Margie. $e editor. 700 1 $a Nass, Sharyl J., $e editor. 700 1 $a Phillips, Jonathan, $e editor. 710 2 $a National Cancer Policy Forum (U.S.) 710 2 $a Institute of Medicine (U.S.). $b Board on Health Care Services. 941 $a 1 952 $l USUX851 $d 20160826113449.0 956 $a http://locator.silo.lib.ia.us/search.cgi?index_0=id&term_0=2F0DCCD26B5811E69AFE1DDBDAD10320 994 $a C0 $b IWAInitiate Another SILO Locator Search